Increased mortality risk associated with statins in the CORONADO study.

Strandberg, Timo E; Kivimäki, Mika

Strandberg, Timo E; Kivimäki, Mika.

Strandberg TE; University of Helsinki and Helsinki University Hospital, Helsinki, Finland; University of Oulu, Centre for Life Course Health Research, Oulu, Finland. Electronic address: timo.strandberg@oulu.fi.
Kivimäki M; University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Diabetes Metab ; 47(3): 101250, 2021 05.

Article in English | MEDLINE | ID: covidwho-1385393

Subject(s)

COVID-19; Diabetes Mellitus, Type 2; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects; Inpatients; SARS-CoV-2

Keywords

COVID-19; Mortality; Statin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Diabetes Metab Journal subject: Endocrinology / Metabolism Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google